Ian Cartwright
Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intestinal Mucosa | 8 | 2024 | 575 | 2.590 |
Why?
| Neutrophils | 8 | 2024 | 1188 | 2.570 |
Why?
| Antiporters | 2 | 2021 | 22 | 1.380 |
Why?
| Acidosis | 2 | 2021 | 88 | 1.300 |
Why?
| Peptide Nucleic Acids | 2 | 2019 | 3 | 1.260 |
Why?
| Centromere | 2 | 2019 | 48 | 1.220 |
Why?
| Colitis | 5 | 2024 | 240 | 1.190 |
Why?
| In Situ Hybridization, Fluorescence | 3 | 2019 | 313 | 1.090 |
Why?
| Peroxidase | 2 | 2024 | 169 | 1.050 |
Why?
| Telomere | 2 | 2019 | 226 | 1.040 |
Why?
| Tight Junction Proteins | 3 | 2024 | 14 | 0.990 |
Why?
| Chromosome Aberrations | 2 | 2019 | 147 | 0.980 |
Why?
| Inflammation | 8 | 2024 | 2664 | 0.910 |
Why?
| Mucositis | 1 | 2023 | 19 | 0.820 |
Why?
| Crohn Disease | 2 | 2023 | 211 | 0.750 |
Why?
| Diet, Paleolithic | 1 | 2021 | 3 | 0.740 |
Why?
| Intestines | 3 | 2023 | 345 | 0.720 |
Why?
| Ileitis | 1 | 2021 | 32 | 0.720 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2021 | 141 | 0.690 |
Why?
| Hydrogen Peroxide | 1 | 2021 | 308 | 0.650 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2021 | 206 | 0.640 |
Why?
| Disease Models, Animal | 4 | 2024 | 3943 | 0.640 |
Why?
| Radiation | 1 | 2019 | 24 | 0.620 |
Why?
| DNA Damage | 2 | 2018 | 364 | 0.600 |
Why?
| Staining and Labeling | 1 | 2019 | 139 | 0.600 |
Why?
| DNA Repair | 2 | 2018 | 205 | 0.580 |
Why?
| Microwaves | 2 | 2019 | 34 | 0.550 |
Why?
| Genomic Instability | 1 | 2017 | 47 | 0.550 |
Why?
| Ovary | 1 | 2018 | 214 | 0.530 |
Why?
| Caspase 3 | 1 | 2017 | 229 | 0.520 |
Why?
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 129 | 0.520 |
Why?
| Chromosome Inversion | 1 | 2015 | 17 | 0.500 |
Why?
| Carcinogenesis | 1 | 2017 | 209 | 0.500 |
Why?
| Cell Transformation, Neoplastic | 1 | 2017 | 325 | 0.470 |
Why?
| Tight Junctions | 3 | 2024 | 75 | 0.420 |
Why?
| Heating | 1 | 2012 | 20 | 0.410 |
Why?
| Chromosomes | 1 | 2012 | 101 | 0.390 |
Why?
| Mice | 11 | 2024 | 16579 | 0.380 |
Why?
| Animals | 16 | 2024 | 34501 | 0.380 |
Why?
| Hydrogen-Ion Concentration | 2 | 2022 | 538 | 0.340 |
Why?
| Colon | 2 | 2021 | 251 | 0.310 |
Why?
| Cricetulus | 3 | 2018 | 104 | 0.300 |
Why?
| CHO Cells | 3 | 2018 | 150 | 0.300 |
Why?
| Cricetinae | 3 | 2018 | 275 | 0.300 |
Why?
| Adenosine | 2 | 2019 | 211 | 0.280 |
Why?
| Halogenation | 2 | 2024 | 20 | 0.280 |
Why?
| Dextran Sulfate | 2 | 2024 | 76 | 0.270 |
Why?
| Ileum | 2 | 2023 | 115 | 0.220 |
Why?
| Mice, Inbred C57BL | 3 | 2024 | 5257 | 0.220 |
Why?
| Epithelial Cells | 3 | 2020 | 1036 | 0.220 |
Why?
| Hypoxia | 4 | 2023 | 1031 | 0.210 |
Why?
| Cells, Cultured | 2 | 2022 | 4008 | 0.210 |
Why?
| Cell Survival | 2 | 2018 | 1077 | 0.210 |
Why?
| Colitis, Ulcerative | 1 | 2024 | 114 | 0.210 |
Why?
| Wound Healing | 2 | 2022 | 310 | 0.200 |
Why?
| Humans | 17 | 2024 | 128524 | 0.190 |
Why?
| Mucous Membrane | 1 | 2023 | 120 | 0.190 |
Why?
| CD11 Antigens | 1 | 2022 | 29 | 0.190 |
Why?
| Salmonella Infections | 1 | 2022 | 52 | 0.190 |
Why?
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2021 | 12 | 0.190 |
Why?
| Dual Specificity Phosphatase 1 | 1 | 2021 | 26 | 0.190 |
Why?
| Bystander Effect | 1 | 2021 | 16 | 0.180 |
Why?
| Cell Hypoxia | 2 | 2020 | 229 | 0.180 |
Why?
| Mucoproteins | 1 | 2020 | 10 | 0.180 |
Why?
| Cell Adhesion | 1 | 2022 | 444 | 0.180 |
Why?
| Gamma Rays | 2 | 2018 | 52 | 0.180 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2021 | 173 | 0.170 |
Why?
| Autophagy-Related Proteins | 1 | 2020 | 41 | 0.170 |
Why?
| Endotoxins | 1 | 2021 | 216 | 0.170 |
Why?
| Organoids | 1 | 2021 | 104 | 0.170 |
Why?
| Leukocyte Disorders | 1 | 2019 | 10 | 0.170 |
Why?
| Mice, Knockout | 2 | 2024 | 2752 | 0.170 |
Why?
| Sodium Dodecyl Sulfate | 1 | 2019 | 23 | 0.170 |
Why?
| Cholangitis, Sclerosing | 1 | 2020 | 70 | 0.170 |
Why?
| Transendothelial and Transepithelial Migration | 1 | 2019 | 30 | 0.170 |
Why?
| Immune System Diseases | 1 | 2019 | 33 | 0.170 |
Why?
| Vesicular Transport Proteins | 1 | 2020 | 84 | 0.160 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2021 | 313 | 0.160 |
Why?
| Neutrophil Activation | 1 | 2019 | 77 | 0.160 |
Why?
| Cell Adhesion Molecules | 1 | 2020 | 172 | 0.160 |
Why?
| Glycolysis | 1 | 2021 | 293 | 0.160 |
Why?
| Sexual and Gender Minorities | 1 | 2022 | 186 | 0.160 |
Why?
| Eosinophils | 1 | 2022 | 323 | 0.160 |
Why?
| Metaphase | 1 | 2019 | 29 | 0.160 |
Why?
| Bile Acids and Salts | 1 | 2020 | 195 | 0.160 |
Why?
| Monocytes | 1 | 2021 | 541 | 0.150 |
Why?
| Linear Energy Transfer | 1 | 2018 | 4 | 0.150 |
Why?
| Micronucleus Tests | 1 | 2018 | 5 | 0.150 |
Why?
| Sequence Analysis, RNA | 1 | 2021 | 428 | 0.150 |
Why?
| Hypersensitivity | 1 | 2022 | 249 | 0.150 |
Why?
| Pyrophosphatases | 1 | 2018 | 21 | 0.150 |
Why?
| Polyphosphates | 1 | 2018 | 37 | 0.150 |
Why?
| Phosphoric Diester Hydrolases | 1 | 2018 | 46 | 0.150 |
Why?
| Radiation, Ionizing | 1 | 2018 | 75 | 0.150 |
Why?
| Indoles | 1 | 2021 | 367 | 0.150 |
Why?
| Nucleotides | 1 | 2018 | 117 | 0.140 |
Why?
| Microbiota | 2 | 2022 | 720 | 0.140 |
Why?
| Cholestasis | 1 | 2020 | 230 | 0.140 |
Why?
| Oxygen | 2 | 2022 | 901 | 0.140 |
Why?
| Cell Line | 3 | 2020 | 2731 | 0.140 |
Why?
| Phosphorylation | 1 | 2021 | 1681 | 0.130 |
Why?
| Up-Regulation | 1 | 2019 | 826 | 0.130 |
Why?
| Signal Transduction | 2 | 2021 | 4829 | 0.130 |
Why?
| Inflammatory Bowel Diseases | 1 | 2020 | 312 | 0.130 |
Why?
| Adaptation, Physiological | 1 | 2019 | 514 | 0.130 |
Why?
| Gene Expression Regulation | 2 | 2021 | 2506 | 0.120 |
Why?
| Rutin | 1 | 2014 | 2 | 0.110 |
Why?
| Radiation-Protective Agents | 1 | 2014 | 27 | 0.110 |
Why?
| Adenocarcinoma | 1 | 2021 | 888 | 0.110 |
Why?
| Membrane Proteins | 1 | 2020 | 1108 | 0.110 |
Why?
| Colorectal Neoplasms | 1 | 2021 | 753 | 0.110 |
Why?
| Equipment Failure Analysis | 1 | 2012 | 131 | 0.100 |
Why?
| Equipment Design | 1 | 2012 | 518 | 0.090 |
Why?
| Fibrosis | 2 | 2023 | 522 | 0.080 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2022 | 257 | 0.080 |
Why?
| Lung | 1 | 2021 | 3741 | 0.070 |
Why?
| HIV Infections | 1 | 2022 | 2703 | 0.070 |
Why?
| Phenotype | 1 | 2015 | 3050 | 0.070 |
Why?
| Female | 2 | 2024 | 68127 | 0.060 |
Why?
| Transcription Factors | 2 | 2022 | 1631 | 0.050 |
Why?
| Leukocyte L1 Antigen Complex | 1 | 2022 | 29 | 0.050 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2022 | 132 | 0.050 |
Why?
| Interleukin-12 | 1 | 2022 | 120 | 0.050 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 147 | 0.050 |
Why?
| CD11c Antigen | 1 | 2022 | 41 | 0.050 |
Why?
| Heme Oxygenase-1 | 1 | 2021 | 59 | 0.050 |
Why?
| Homosexuality, Male | 1 | 2022 | 176 | 0.050 |
Why?
| Heme | 1 | 2021 | 76 | 0.050 |
Why?
| Ursodeoxycholic Acid | 1 | 2020 | 19 | 0.040 |
Why?
| Immunologic Factors | 1 | 2022 | 229 | 0.040 |
Why?
| Male | 2 | 2024 | 62883 | 0.040 |
Why?
| Mammals | 1 | 2022 | 269 | 0.040 |
Why?
| Caco-2 Cells | 1 | 2020 | 71 | 0.040 |
Why?
| Tyrosine | 1 | 2021 | 216 | 0.040 |
Why?
| Response Elements | 1 | 2020 | 89 | 0.040 |
Why?
| Tumor Cells, Cultured | 1 | 2021 | 927 | 0.040 |
Why?
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2018 | 8 | 0.040 |
Why?
| Allergens | 1 | 2022 | 383 | 0.040 |
Why?
| HeLa Cells | 1 | 2020 | 603 | 0.040 |
Why?
| Dinucleoside Phosphates | 1 | 2018 | 28 | 0.040 |
Why?
| Disease Susceptibility | 1 | 2020 | 334 | 0.040 |
Why?
| Promoter Regions, Genetic | 1 | 2020 | 1199 | 0.030 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2020 | 1190 | 0.030 |
Why?
| Macrophages | 1 | 2021 | 1463 | 0.030 |
Why?
| Cell Movement | 1 | 2018 | 937 | 0.030 |
Why?
| Transcription, Genetic | 1 | 2018 | 1398 | 0.020 |
Why?
| Biomarkers | 1 | 2022 | 3881 | 0.020 |
Why?
| Histones | 1 | 2014 | 581 | 0.020 |
Why?
|
|
Cartwright's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|